NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Packaged Foods · USD

BioHarvest Sciences Inc. Common Stock (BHST) Stock Analysis

BioHarvest Sciences Inc. Common Stock (BHST) is a Packaged Foods stock listed on NASDAQ and quoted in US Dollar.

BHST

$1.82

+$0.02 (+1.11%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare BHST with… →

BHST Key Statistics

As of Sep 4, 2026
Trading
Open
$1.80
Previous Close
$1.80
Day's Range
1.80–1.85
52-Week Range
1.80–12.80
Volume
49.70K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.35
Valuation
Market Cap
$41.26M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.16
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.51
Financials (FY)
Revenue (FY)
$34.51M+37.00%
Net Income (FY)
−$11.14M
Profit marginThe share of revenue left as profit after all costs and taxes.
−31.21%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
22.67M
1-Year Return
−76.08%
Dividend and dates
Earnings Date
November 12, 2026estimated
Avg Volume
51.17K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

BHST Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−64.93%
2025−16.02%
2024+11.75%
2023−27.52%
2022−39.44%
2021+24.14%

As of September 4, 2026.

BHST Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$34.51M−$11.14M−32.3%
2024$25.19M−$12.91M−51.3%
2023$12.67M−$12.56M−99.1%
2022$5.50M−$11.24M−204.4%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$34.51M$20.48M−$5.58M−$11.14M−32.3%
2024$25.19M$13.94M−$6.99M−$12.91M−51.3%
2023$12.67M$5.63M−$9.97M−$12.56M−99.1%
2022$5.50M$1.22M−$10.61M−$11.24M−204.4%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

BHST Valuation vs Packaged Foods Median

Median of 76 stocks
MetricBHSTPackaged Foods medianvs median
P/S ratio1.160.6579% above
Profit margin−31.21%0.50%31.7 pts below

Medians across 76 Packaged Foods stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values BioHarvest Sciences Inc. Common Stock (BHST) at $41.26M. It is classified in the Packaged Foods industry, within the Consumer Defensive sector. The company reports 89 employees.

The most recent close on file for BHST is $1.82, dated September 4, 2026. That is +$0.02 (+1.11%) against the previous close. The 52-week range on file runs from $1.80 to $12.80. The latest close sits 1.11% above that 52-week low.

Financial Health

In fiscal 2025, BioHarvest Sciences Inc. Common Stock reported revenue of $34.51M. Against the prior fiscal year total of $25.19M, that is a change of +37.00%. The same year closed with a net loss of $11.14M. The reported profit margin is −31.21%. That is 31.7 percentage points below the Packaged Foods median of 0.5%. Earnings per share on a trailing basis come to −0.51.

Across the 4 fiscal years on file, revenue moves from $5.50M in 2022 to $34.51M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 1.16 times revenue. On price-to-sales that is 79.06% above the Packaged Foods median of 0.65. 76 Packaged Foods companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 1.35. Annualized volatility over the trailing 5 years is 75.35%. Over the trailing twelve months the price has returned −76.08%. Measured over 5 years, that is −30.47% a year compounded.

Growth & Income

No dividend is on file for BHST.

2026 is still running; the price is −64.93% year to date. The strongest complete calendar year on file is 2021 at +24.14%; the weakest is 2022 at −39.44%. Of the 5 complete calendar years on file, 2 finished higher.

Peer Comparison

BioHarvest Sciences Inc. Common Stock (BHST) operates in the Packaged Foods industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
BioHarvest Sciences Inc. Common Stock BHST $41.26M —
The Kraft Heinz Company KHC $29.47B —
General Mills, Inc. GIS $20.47B —
Saputo Inc. SAP.TO $15.93B 23.1

The Packaged Foods industry average P/E ratio is 15.5x. BioHarvest Sciences Inc. Common Stock has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Packaged Foods Stocks

KHC

The Kraft Heinz Company

$29.47B

 GIS

General Mills, Inc.

$20.47B

 SAP.TO

Saputo Inc.

$15.93B

 MKC

McCormick & Company, Incorporated

$14.00B

 JBS

JBS N.V.

$13.95B

 SJM

The J. M. Smucker Company

$13.47B
View all Packaged Foods stocks →

Popular Consumer Defensive Stocks

WMT

Walmart Inc.

$852.63B

 COST

Costco Wholesale Corporation

$406.11B

 KO

The Coca-Cola Company

$378.93B

 PG

The Procter & Gamble Company

$340.13B

 PM

Philip Morris International Inc.

$284.49B
View all Consumer Defensive stocks →

About BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.

Visit website →